Maximum Daily Dose of Enoxaparin
The maximum daily dose of enoxaparin for adults is 200 mg per day when used for treatment of venous thromboembolism (VTE) in patients with cancer, or 100 mg per dose (maximum for first 2 doses) when used with fibrinolytic therapy in acute coronary syndromes for patients under 75 years of age. 1, 2
Context-Specific Maximum Doses
The maximum dose varies significantly based on clinical indication:
Acute Coronary Syndromes (ACS)
- With fibrinolytic therapy (age <75 years): Maximum 100 mg for the first 2 doses when dosed at 1 mg/kg subcutaneously every 12 hours 1, 3
- With fibrinolytic therapy (age ≥75 years): Maximum 75 mg for the first 2 doses when dosed at 0.75 mg/kg subcutaneously every 12 hours 1, 3
- Standard ACS therapy: 1 mg/kg subcutaneously every 12 hours with no specified maximum beyond the weight-based calculation 1, 3
Venous Thromboembolism Treatment
- Initial treatment: 1 mg/kg every 12 hours OR 1.5 mg/kg once daily 2, 4
- Cancer patients (long-term): 200 mg once daily for the first month, then 150 mg once daily 2
- This represents the highest total daily dose documented in guidelines
VTE Prophylaxis
- Standard prophylaxis: 40 mg once daily 2
- Surgical prophylaxis: Maximum 40 mg once daily after initial perioperative dosing 2
Critical Dosing Considerations
Renal Impairment
When creatinine clearance <30 mL/min, all doses must be reduced 1, 3, 5:
- Treatment doses: 1 mg/kg once daily (instead of twice daily or 1.5 mg/kg)
- This effectively halves the maximum daily dose in severe renal insufficiency
- Enoxaparin accumulation occurs with renal dysfunction, increasing bleeding risk 6
Obesity
- Doses should be based on actual body weight up to 144 kg for enoxaparin 6
- No maximum dose cap is specified for obese patients, but monitoring anti-factor Xa levels may be considered 7
- Studies show increased supratherapeutic anti-Xa levels in obese patients, with mean doses reduced to 0.84 mg/kg 8
Low Body Weight
- Patients <50 kg receiving fondaparinux get 5 mg (for comparison), but enoxaparin dosing remains weight-based without a specified minimum 4
- In extremely underweight patients (<45 kg), standard prophylactic doses (30-40 mg daily) may be excessive 9, 10
Important Caveats
Do not switch between enoxaparin and unfractionated heparin during treatment due to increased bleeding risk 5. This is a Class III (Harm) recommendation.
The 100 mg maximum for ACS with fibrinolytics applies only to the first 2 doses - subsequent doses continue at the full weight-based calculation 1, 3. This cap exists specifically to reduce bleeding risk in the acute fibrinolytic setting.
For once-daily dosing at 1.5 mg/kg, there is no specified maximum dose in adults, though this can theoretically exceed 200 mg in patients >133 kg 2, 11. The evidence supporting once-daily dosing is robust, showing equivalent efficacy to twice-daily regimens 11.
Monitoring Considerations
Anti-factor Xa monitoring is not routinely recommended but should be considered in 6, 7:
- Severe renal insufficiency (CrCl <30 mL/min)
- Obesity
- Pregnancy
- Extremes of body weight
Target peak anti-Xa levels (measured 4 hours post-dose):
- Twice-daily dosing: 0.6-1.0 IU/mL
- Once-daily dosing: 1.0-2.0 IU/mL 6